logo

Assertio Therapeutics Inc. (ASRT)



Trade ASRT now with
  Date
  Headline
5/17/2021 6:38:14 AM HEXO To Buy All Of 48North's Common Shares In An All-share Transaction
5/17/2021 6:35:23 AM Assertio Files Certificate Of Amendment To Implement 1-to-4 Reverse Split
12/15/2020 9:14:18 AM Assertio Plans Restructuring, To Cut Costs; Names Dan Peisert CEO
5/20/2020 8:50:33 AM Assertio Holdings Announces Closing Of Merger With Zyla Life Sciences
3/9/2020 4:09:31 PM Assertio Therapeutics Q4 Loss/share $2.65 Vs. Loss $0.38 Year Ago
2/28/2018 7:59:10 AM RBC Capital Markets Is Cutting Depomed Inc. (DEPO) FY20 Rev. Estimate To 274.3 M From 322.4 M
2/28/2018 7:58:58 AM RBC Capital Markets Is Lowering Depomed Inc. (DEPO) FY19 Rev. Estimate To 266.2 M From 299.6 M
2/28/2018 7:58:47 AM RBC Capital Markets Is Lowering Depomed Inc. (DEPO) FY18 Rev. Estimate To 269.1 M From 286.0 M
2/28/2018 7:58:20 AM RBC Capital Markets Is Cutting Depomed Inc. (DEPO) FY20 Estimate To 1.20 From 1.24
2/28/2018 7:58:02 AM RBC Capital Markets Is Cutting Depomed Inc. (DEPO) FY19 Estimate To 1.14 From 1.16
2/28/2018 7:57:52 AM RBC Capital Markets Is Raising Depomed Inc. (DEPO) FY18 Estimate To 0.90 From 0.83
12/6/2017 1:09:08 PM RBC Capital Markets Is Lowering Depomed Inc. (DEPO) 2018 Rev. Estimate To 286.0 M From 396.2 M
12/6/2017 1:08:30 PM RBC Capital Markets Is Lowering Depomed Inc. (DEPO) 2017 Rev. Estimate To 376.5 M From 381.7 M
11/8/2017 9:26:49 AM RBC Capital Markets Is Lowering Depomed Inc. (DEPO) 4Q17 Estimate To 0.12 From 0.17
11/8/2017 9:26:35 AM RBC Capital Markets Is Cutting Depomed Inc. (DEPO) 4Q17 Rev. Estimate To 90.6 M From 104.6 M
11/8/2017 9:26:16 AM RBC Capital Markets Is Raising Depomed Inc. (DEPO) 2019 Estimate To 0.65 From 0.58
11/8/2017 9:26:04 AM RBC Capital Markets Is Increasing Depomed Inc. (DEPO) 2018 Estimate To 0.59 From 0.55